Dr. Ihsan Al-Khalil, MD

Media Releases

Get to know Pediatric Hematologist-Oncologist Dr. Ihsan Al-Khalil, who serves patients in Lumberton, North Carolina.

Dr. Al-Khalil is a fellowship-trained pediatric hematologist-oncologist with over five decades of experience in his field. He sees patients at Southeastern Family Medicine Residency Clinic in Lumberton, North Carolina.

With an unwavering commitment to his speciality, he is board-certified in pediatrics and pediatric hematology-oncology by the American Board of Pediatrics (ABP). The mission of the ABP is to advance child health by certifying pediatricians who meet standards of excellence and are committed to continuous learning and improvement.

A 1972 graduate of the University of Damascus, Faculty of Medicine in Syria, Dr. Al-Khalil relocated to the United States to complete his training. He performed his internship at Iowa Methodist Medical Center and his residency in pediatrics at the Medical College of Ohio at Toledo. Wanting to further his education, he completed his fellowships in pediatric hematology-oncology at the University of Connecticut and Yale-New Haven Hospital.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease. More specifically, a pediatric hematologist-oncologist treats children and teens from birth through young adulthood.

Among the doctor’s most notable achievements, he is the recipient of Patients’ Choice Award (2016, 2017) and Compassionate Doctor Recognition (2016, 2017).

Recommended Articles

• New Study Discovers How Lymphoma Affects Survivors’ Ability to Work

  Young adults in many countries pride themselves on their work. They have worked hard to get to where they are and there is a huge sense of accomplishment in joining the adult world and being able to provide for themselves and their new families if applicable. When cancer comes along, their ability...

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...

• What Are Lymphocytes?

  A lymphocyte is a type of white blood cell (WBC) that has a significant function in the body's immune system. Lymphocytes function by properly responding to infectious microorganisms and other foreign invaders in the body. Lymphocytes can work alone, but some of them are also capable of...

• This New Zealand Native Beat Cancer Eight Times

  Being diagnosed with cancer can be a world-shaking experience. Going through the necessary chemotherapy and radiation treatment to beat cancer can be a difficult struggle, but coming out cancer-free feels incredibly liberating.Maybe it’s that feeling of having beaten cancer that can make suffering...

• Dreams Do Come True: 9-year-old Baseball Fanatic Signed Onto Team

  Like most young baseball fans, John “Parker” Staples' room is covered in memorabilia from his favorite team, the Washington Nationals, but unlike most kids, Parker's room is at the University of Virginia Children's Hospital.John “Parker” Staples, is nine-year old who was diagnosed with...

• The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer

  On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...